跳至主要内容
临床试验/NCT04513509
NCT04513509
已完成
不适用

The Surrogate Marker of Rate Control in Patients With Atrial Fibrillation

National Taiwan University Hospital1 个研究点 分布在 1 个国家目标入组 13 人2020年10月21日

概览

阶段
不适用
干预措施
Atenolol, Bisoprolol, Metoprolol, Nebivolol, Propranolol, Diltiazem, Verapamil, digoxin
疾病 / 适应症
Atrial Fibrillation
发起方
National Taiwan University Hospital
入组人数
13
试验地点
1
主要终点
Change of Maximal Oxygen consumption
状态
已完成
最后更新
3个月前

概览

简要总结

To search for the best marker for the patients in atrial fibrillation with rate control

详细描述

In an aging society, the prevalence of atrial fibrillation is increasing. The main treatment strategy is to reduce the complications of embolic stroke and heart failure. Among these patients, a group of them will choose to have "rate control" based on the heart conditions and the preference of the patients. The strategy is to control the ventricular rate by drugs to prevent the heart from failure. However, when the physicians attempt to do so, they encounter two questions: how much is the optimal drug dose? And what is the best marker we are looking to? To answer these questions, the investigators design a prospective, cross-over study to explore this issue. The participants will do cardiopulmonary exercise test (CPET) before and after treatment. They will receive another CPET if drug dose is titrated up. With the study, the investigators will understand whether a resting heart rate can be a good marker for optimal drug dosage, and what is the optimal range of heart rate the physicians should target.

注册库
clinicaltrials.gov
开始日期
2020年10月21日
结束日期
2022年7月1日
最后更新
3个月前
研究类型
Interventional
研究设计
Sequential
性别
All

研究者

责任方
Sponsor

入排标准

入选标准

  • 18\~90 years old
  • Rate control is preferred after shared decision making

排除标准

  • cannot cooperate with or complete CPET
  • has contraindication for CPET, such as uncontrolled heart failure, hypertension, angina, valvular heart disease, lung function impariment that SaO2\<90% at room air.
  • Ventricular rate below 80/min before any medication
  • Permanent pacemaker implanted

研究组 & 干预措施

rate control

干预措施: Atenolol, Bisoprolol, Metoprolol, Nebivolol, Propranolol, Diltiazem, Verapamil, digoxin

结局指标

主要结局

Change of Maximal Oxygen consumption

时间窗: 0, 3, 6 months

acquire the data by Cardiopulmonary exercise test (CPET) with different (low and high) drug dosages for rate control

研究点 (1)

Loading locations...

相似试验